What type of study is this?

This is a Quantitative Study study.

September 30, 2025Journal of Viral HepatitisOpen Access

HCV Testing and Treatment of Adults in the United States: 2014 Through 2021—Data From Two National Commercial Testing Laboratories

View Full Paper

Ask AI

Bookmark

Authors

Analysis of HCV testing and treatment trends in adults, revealing challenges to elimination goals.

From 2014 to 2021, 4.8% of those tested for HCV antibodies were positive, indicating ongoing public health challenges.
Of 3.1 million tested for HCV RNA, 62.6% were viremic, and 34.5% of these were treated with a cure rate of 96%.
Treatment rates were highest among older individuals, urban residents, and those diagnosed by reflex testing, highlighting disparities.
COVID-19 impacted testing and treatment, resulting in a 23% decline in the number of persons treated for HCV in 2021.

Ghany et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

September 30, 2025Journal of Viral HepatitisOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Analysis of HCV testing and treatment trends in adults, revealing challenges to elimination goals.

From 2014 to 2021, 4.8% of those tested for HCV antibodies were positive, indicating ongoing public health challenges.
Of 3.1 million tested for HCV RNA, 62.6% were viremic, and 34.5% of these were treated with a cure rate of 96%.
Treatment rates were highest among older individuals, urban residents, and those diagnosed by reflex testing, highlighting disparities.
COVID-19 impacted testing and treatment, resulting in a 23% decline in the number of persons treated for HCV in 2021.

Ghany et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark